Press Release | January 10, 2025
Primrose Bio to Collaborate with Serum Institute of India to Develop a Novel Multi-Antigen Vaccine
Read More
News | January 10, 2025
Lilly ventures into pulmonary fibrosis with startup Mediar
Read More
Press Release | January 10, 2025
Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular Anomalies
Read More
